These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22077725)

  • 1. Effects of estrogen metabolite 2-methoxyestradiol on tumor suppressor protein p53 and proliferation of breast cancer cells.
    Siebert AE; Sanchez AL; Dinda S; Moudgil VK
    Syst Biol Reprod Med; 2011 Dec; 57(6):279-87. PubMed ID: 22077725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells.
    Dinda S; Sanchez A; Moudgil V
    Oncogene; 2002 Jan; 21(5):761-8. PubMed ID: 11850804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells.
    Hurd C; Khattree N; Dinda S; Alban P; Moudgil VK
    Oncogene; 1997 Aug; 15(8):991-5. PubMed ID: 9285694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-methoxyestradiol-mediated anti-tumor effect increases osteoprotegerin expression in osteosarcoma cells.
    Benedikt MB; Mahlum EW; Shogren KL; Subramaniam M; Spelsberg TC; Yaszemski MJ; Maran A
    J Cell Biochem; 2010 Apr; 109(5):950-6. PubMed ID: 20082321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
    Seeger H; Wallwiener D; Kraemer E; Mueck AO
    Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
    Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
    Zhang X; Huang H; Xu Z; Zhan R
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis.
    Kampa M; Nifli AP; Charalampopoulos I; Alexaki VI; Theodoropoulos PA; Stathopoulos EN; Gravanis A; Castanas E
    Exp Cell Res; 2005 Jul; 307(1):41-51. PubMed ID: 15922725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effect of 2-methoxyestradiol on cell cycle events in human osteosarcoma 143B cells.
    Gołebiewska J; Rozwadowski P; Spodnik JH; Knap N; Wakabayashi T; Woźniak M
    Acta Biochim Pol; 2002; 49(1):59-65. PubMed ID: 12136957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis.
    Shimada K; Nakamura M; Ishida E; Kishi M; Konishi N
    Carcinogenesis; 2003 Jun; 24(6):1067-75. PubMed ID: 12807754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study.
    Lavigne JA; Takahashi Y; Chandramouli GV; Liu H; Perkins SN; Hursting SD; Wang TT
    Breast Cancer Res Treat; 2008 Jul; 110(1):85-98. PubMed ID: 17687646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
    Mueck AO; Seeger H; Wallwiener D
    Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle.
    Barchiesi F; Jackson EK; Fingerle J; Gillespie DG; Odermatt B; Dubey RK
    Circ Res; 2006 Aug; 99(3):266-74. PubMed ID: 16794187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
    Seeger H; Wallwiener D; Mueck AO
    Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
    Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
    Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.